Joseph Chao Selected Research

Joseph Chao Research Topics

Disease

51	Neoplasms (Cancer) 06/2022 - 02/2010
20	Stomach Neoplasms (Stomach Cancer) 06/2022 - 06/2015
10	Adenocarcinoma 01/2022 - 02/2015
6	Microsatellite Instability 06/2022 - 07/2018
5	Esophageal Neoplasms (Esophageal Cancer) 02/2022 - 10/2008
5	Breast Neoplasms (Breast Cancer) 10/2017 - 09/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 09/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2017
2	Carcinoma (Carcinomatosis) 10/2019 - 01/2017
2	Weight Loss (Weight Reduction) 01/2019 - 09/2004
1	Ascites 01/2022
1	Colitis 01/2022
1	Disease Progression 01/2022
1	Liver Diseases (Liver Disease) 01/2019
1	Circulating Neoplastic Cells 01/2019
1	Chest Pain (Chest Pains) 12/2017
1	Adenoid Cystic Carcinoma (Cylindroma) 05/2017
1	Obesity 01/2017
1	Fatigue 01/2017
1	Peritoneal Diseases 01/2017
1	Peritoneal Neoplasms 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 11/2016
1	Hemorrhage 11/2016
1	Exanthema (Rash) 11/2016
1	Disseminated Intravascular Coagulation 11/2016
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2016

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
8	Immune Checkpoint InhibitorsIBA 06/2022 - 07/2018
8	pembrolizumabIBA 01/2022 - 07/2018
5	PlatinumIBA 01/2022 - 01/2016
4	B7-H1 AntigenIBA 01/2022 - 07/2018
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 10/2017
4	Trastuzumab (Herceptin)FDA Link 11/2019 - 02/2015
4	IT-101IBA 12/2017 - 08/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2014
3	Pharmaceutical PreparationsIBA 01/2019 - 04/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 09/2014
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2019
2	fibrin fragment D (D-dimer)IBA 10/2017 - 08/2017
2	Interleukin-6 (Interleukin 6)IBA 10/2017 - 08/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2017 - 08/2017
2	CamptothecinIBA 04/2016 - 08/2013
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2016 - 09/2013
2	Biological ProductsIBA 04/2016 - 08/2010
2	Imatinib Mesylate (Gleevec)FDA Link 08/2010 - 02/2010
1	NucleotidesIBA 06/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	Immunomodulating AgentsIBA 07/2021
1	Programmed Cell Death 1 ReceptorIBA 07/2021
1	LigandsIBA 10/2020
1	Yttrium-90IBA 01/2020
1	durvalumabIBA 01/2020
1	tremelimumabIBA 01/2020
1	Phosphotransferases (Kinase)IBA 11/2019
1	tyrosine receptor (receptor, tyrosine)IBA 11/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2019
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	4-O-deacetyl vinorelbineIBA 01/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	BilirubinIBA 01/2019
1	XELOXIBA 12/2018
1	SaltsIBA 12/2018
1	Circulating Tumor DNAIBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2017
1	binimetinibIBA 10/2017
1	C-Reactive ProteinIBA 10/2017
1	Vorinostat FDA Link 05/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2016

Therapy/Procedure

26	Therapeutics 01/2022 - 02/2010
24	Drug Therapy (Chemotherapy) 02/2022 - 08/2010
10	Immunotherapy 06/2022 - 06/2018
5	Neoadjuvant Therapy 03/2021 - 10/2008
5	Adjuvant Chemotherapy 01/2019 - 06/2015
4	Radiotherapy 01/2022 - 06/2015
2	Cytoreduction Surgical Procedures 01/2022 - 01/2017
2	Hyperthermic Intraperitoneal Chemotherapy 01/2022 - 01/2017
2	Precision Medicine 01/2020 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 06/2015
1	Palliative Care (Palliative Therapy) 09/2020
1	Aftercare (After-Treatment) 01/2020
1	Microspheres (Microsphere) 01/2020
1	Esophagectomy 08/2019
1	Pancreatectomy 01/2019
1	Splenectomy 01/2019
1	Activities of Daily Living (ADL) 10/2017
1	Jejunostomy 01/2017
1	Mastectomy (Mammectomy) 11/2016
1	Artificial Respiration (Mechanical Ventilation) 11/2016